Quest Diagnostics reported strong top-line and bottom-line growth driven by strategic acquisitions, operational improvements, and expansion in advanced diagnostics. While there were challenges related to tariffs, wage increases, and potential legislative impacts, the company managed these within its guidance and raised its full-year outlook.

Company Guidance

During the Quest Diagnostics second quarter 2025 conference call, the company raised its full-year 2025 guidance, highlighting a strong quarter with a 15.2% increase in top-line growth, including a 5.2% organic revenue growth. Adjusted earnings per share rose by 11.5% due to productivity gains from automation and digitization. The company reported consolidated revenues of $2.76 billion, with diagnostic information services up 15.7%. Total volume increased by 16.3%, driven primarily by acquisitions like LifeLabs, which contributed approximately 8% to the 10% growth from M&A. The adjusted EPS for the quarter was $2.62, with cash from operations increasing 67.1% year-over-year. The updated full-year guidance projects revenues between $10.8 billion and $10.92 billion, with adjusted EPS in the range of $9.63 to $9.83. Organic revenue growth is expected to be between 3.5% to 4%, with further contributions from acquisitions. The company also emphasized its focus on operational improvements through Project Nova and the Invigorate program, aiming for annual cost savings and productivity improvements of 3%.

Strong Top-Line Growth

Quest Diagnostics reported a 15.2% increase in top-line growth, with 5.2% organic revenue growth driven by innovative clinical solutions and expanded business from enterprise accounts.

Operational Excellence and Cost Savings

The company targeted 3% annual cost savings through its Invigorate program, deploying automation and AI technologies. Employee retention improved, contributing to productivity gains.

Advanced Diagnostics Expansion

Double-digit revenue growth was achieved in advanced cardiometabolic, autoimmune, and brain health diagnostics, with significant growth in Alzheimer's disease testing.

Acquisitions Driving Growth

Acquisitions contributed significantly to growth, particularly the LifeLabs acquisition, which accounted for approximately 8% of the 10% M&A-driven growth.

Increased Full-Year 2025 Guidance

The full-year revenue guidance was raised to between $10.8 billion and $10.92 billion, with adjusted EPS expected to be in the range of $9.63 to $9.83.

Quest Diagnostics (DGX) Earnings, Revenues Date & History

The upcoming earnings date is based on a company’s previous reporting, and may be updated when the actual date is announced

Daily Earnings Calendar >

DGX Earnings History

Report Date	Fiscal Quarter	Forecast / EPS	Last Year's EPS	EPS YoY Change	Slides	Play Transcript
Oct 28, 2025	2025 (Q3)	2.50 / -	2.3	―	―	―
Jul 22, 2025	2025 (Q2)	2.57 / 2.62	2.35	11.49% (+0.27)
Apr 22, 2025	2025 (Q1)	2.15 / 2.21	2.04	8.33% (+0.17)
Jan 30, 2025	2024 (Q4)	2.19 / 2.23	2.15	3.72% (+0.08)
Oct 22, 2024	2024 (Q3)	2.26 / 2.30	2.22	3.60% (+0.08)	―
Jul 23, 2024	2024 (Q2)	2.33 / 2.35	2.3	2.17% (+0.05)	―
Apr 23, 2024	2024 (Q1)	1.86 / 2.04	2.04	0.00% (0.00)	―
Feb 01, 2024	2023 (Q4)	2.11 / 2.15	1.98	8.59% (+0.17)
Oct 24, 2023	2023 (Q3)	2.19 / 2.22	2.36	-5.93% (-0.14)	―
Jul 26, 2023	2023 (Q2)	2.27 / 2.30	2.36	-2.54% (-0.06)	―

The table shows recent earnings report dates and whether the forecast was beat or missed. See the change in forecast and EPS from the previous year.

Beat

Missed

DGX Earnings-Related Price Changes

Report Date	Price 1 Day Before	Price 1 Day After	Percentage Change
Jul 22, 2025	$166.45	$178.24	+7.08%
Apr 22, 2025	$161.13	$172.06	+6.78%
Jan 30, 2025	$153.98	$162.63	+5.62%
Oct 22, 2024	$145.28	$155.23	+6.85%

Earnings announcements can affect a stock’s price. This table shows the stock's price the day before and the day after recent earnings reports, including the percentage change.

FAQ

When does Quest Diagnostics (DGX) report earnings?

Quest Diagnostics (DGX) is schdueled to report earning on Oct 28, 2025, Before Open (Confirmed).

What is Quest Diagnostics (DGX) earnings time?

Quest Diagnostics (DGX) earnings time is at Oct 28, 2025, Before Open (Confirmed).

Where can I see when companies are reporting earnings?

You can see which companies are reporting today on our designated earnings calendar.

What companies are reporting earnings today?

You can see a list of the companies which are reporting today on TipRanks earnings calendar.

What is DGX EPS forecast?

DGX EPS forecast for the fiscal quarter 2025 (Q3) is 2.5.

Become an Expert with TipRanks Premium

What am I Missing?

Make informed decisions based on Top Analysts' activity

Know what industry insiders are buying

Get actionable alerts from top Wall Street Analysts

Find out before anyone else which stock is going to shoot up

Get powerful stock screeners & detailed portfolio analysis

Subscribe Now See Plans & Pricing